Espinoza DJA, Rodríguez OMF, Valverde ST, Sánchez HA, Lara PJI, Carrillo HRM

Language: Spanish
References: 14
Page: 28-33
PDF size: 225.32 Kb.

ABSTRACT

We present the case of a 30-year-old woman who underwent deceased-donor kidney transplantation 6 years before presenting to her routine nephrology follow-up with fever, abdominal pain, and chronic diarrhea. We describe the diagnostic workup, culminating in the detection of Mycobacterium bovis on tissue culture. She is currently under treatment (month 9/12), reports no symptoms, has no adverse drug effects, and maintains preserved graft function. We also review the literature on intestinal tuberculosis in immunocompromised patients, highlighting diagnostic challenges and the importance of coordination between primary, secondary, and tertiary care.

REFERENCES

1. Sorohan BM, Ismail G, Tacu D, Obrișcă B, Ciolan G, GînguC, Sinescu I, Baston C. Mycobacterium tuberculosis infectionafter kidney transplantation: a comprehensive review.Pathogens. 2022;11(9):1041. doi:10.3390/pathogens11091041.

2. Keane J, Gershon S, Wise RP, Mirabile-Levens E, KasznicaJ, Schwieterman WD, et al. Tuberculosis associated withinfliximab, a tumor necrosis factor alpha-neutralizingagent. N Engl J Med. 2001;345(15):1098-104. doi:10.1056/NEJMoa011110.

3. Subramanian AK, Theodoropoulos NM. Mycobacteriumtuberculosis infections in solid organ transplantation: guidelinesfrom the Infectious Diseases Community of Practiceof the American Society of Transplantation. Clin Transplant.2019;33(9):e13513. doi:10.1111/ctr.13513.

4. Moule MG, Cirillo JD. Mycobacterium tuberculosis disseminationplays a critical role in pathogenesis. Front Cell InfectMicrobiol. 2020;10:65. doi:10.3389/fcimb.2020.00065.

5. Cheng W, Zhang S, Li Y, Wang L, Xie Y, Liu Y, et al. Intestinaltuberculosis: clinicopathological profile and theimportance of a high degree of suspicion. Trop Med IntHealth. 2019;24(1):81-90. doi:10.1111/tmi.13182.

6. Gan H, Mely M, Zhao J, Zhu L. An analysis of the clinical,endoscopic, and pathologic features of intestinal tuberculosis.J Clin Gastroenterol. 2016;50(6):470-5. doi:10.1097/MCG.0000000000000497.

7. Riquelme A, Calvo M, Salech F, Valderrama S, Pattillo A,Arellano M, et al. Value of adenosine deaminase (ADA)in ascitic fluid for the diagnosis of tuberculous peritonitis.Rev Med Chil. 2006;134(6):699-705. doi:10.4067/S0034-98872006000600006.

8. Sharma SK, Kohli M, Yadav RN, Chaubey J, Bhasin D,Sreenivas V, et al. Evaluating the diagnostic accuracy ofXpert MTB/RIF assay in extrapulmonary tuberculosis: amulticenter retrospective study. Eur Respir J. 2014;44(4):1090-3. doi:10.1183/09031936.00059014.

9. Patel B, Yagnik VD. Clinical and laboratory features of intestinaltuberculosis. Clin Exp Gastroenterol. 2018;11:97-103. doi:10.2147/CEG.S154235.

10. Urabinahatti KA, Singh AK, Nayak A, Gupta P, ReddyR, Kumar S, et al. Abdominal tuberculosis: an epidemiologicalprofile and management of 40 cases in a tertiarysetup. Int Surg J. 2016;3(3):1653-8. https://doi.org/q57w

11. World Health Organization. Global tuberculosis report2024. Annex 2: data on TB notifications by form of disease[Internet]. Geneva: WHO; 2024. Disponible en:https://www.who.int/teams/global-programme-on-tuberculosis-and-lung-health/tb-reports/global-tuberculosis-report-2024

12. Tobin EH, Khatri AM. Abdominal tuberculosis. In: Stat-Pearls [Internet]. Treasure Island (FL): StatPearls Publishing;2025 Jan. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK556115/

13. Al-Mofleh IA. Abdominal tuberculosis: epidemiology, presentation,diagnosis and treatment. Saudi J Gastroenterol.2021;27(5):261-74. doi:10.4103/sjg.sjg_148_21.

14. Secretaría de Salud. Boletín epidemiológico de tuberculosis2023–2024 [Internet]. México: Dirección General deEpidemiología; 2024. Disponible en: https://www.gob.mx/salud/epidemiologia